No connection

Search Results

FHN

NEUTRAL
$24.21 Live
First Horizon Corporation · NYSE
Target $26.84 (+10.9%)
$17.57 52W Range $26.56

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Apr 27, 2026
Market cap
$11.56B
P/E
12.17
ROE
11.3%
Profit margin
29.9%
Debt/Equity
N/A
Dividend yield
2.81%

AI Analysis

AI-powered fundamental assessment

Confidence
75%
FHN presents a stark contrast between attractive valuation and deteriorating fundamental health, highlighted by a weak Piotroski F-Score of 2/9. While the current price of $24.21 is a discount to both the Graham Number ($28.16) and the growth-based Intrinsic Value ($58.7), the low health score and bearish insider activity suggest significant underlying risks. These concerns are partially offset by strong earnings growth (29.3% YoY) and a consistent track record of beating analyst estimates. Consequently, the stock is a high-risk value play where growth metrics clash with poor deterministic health indicators.

Key Strengths

Trading below Graham Number ($28.16) and Intrinsic Value ($58.7)
Strong earnings growth of 29.3% YoY
Consistent earnings beat track record (3/4 most recent quarters)
Low P/E ratio (12.17) relative to sector averages
Sustainable dividend payout ratio of 31.16%

Key Risks

Very weak Piotroski F-Score (2/9) indicating poor financial health
Bearish insider sentiment with significant selling by the CEO and officers
Bearish technical trend (0/100)
Low Return on Assets (ROA) of 1.26%
Exposure to regional banking sector volatility
AI Fair Value Estimate
Based on comprehensive analysis
$31.5
+30.1% above current price

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
66
Strong
Value
85
Future
78
Past
80
Health
20
Dividend
65
AI Verdict
Value Trap Risk
Key drivers: Deep valuation discount, Strong EPS growth, Critical failure in Piotroski health score, Insider divestment
Confidence
80%
Value
85/100

Ref P/E, PEG, Graham Number

Positives
  • Price < Graham Number
  • Low Forward P/E of 10.29
Watchpoints
  • PEG ratio of 1.76 suggests growth is not entirely cheap
Future
78/100

Ref Growth rates

Positives
  • 29.3% YoY Earnings Growth
  • Consistent positive earnings surprises
Watchpoints
  • Technical trend is currently 0/100
Past
80/100

Ref Historical trends

Positives
  • 1Y price change of +40.1%
  • Strong historical EPS beat rate
Watchpoints
  • Recent 1W price dip
Health
20/100

Ref Altman Z-Score, Piotroski F-Score

Positives
  • Positive profit margins
Watchpoints
  • Piotroski F-Score of 2/9 is critically low
Dividend
65/100

Ref Yield, Payout

Positives
  • Low payout ratio (31.16%)
  • Consistent dividend rate
Watchpoints
  • Modest yield of 2.81%

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$24.21
Analyst Target
$26.84
Upside/Downside
+10.9%

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for FHN and closest competitors.

Updated 2026-04-24
FHN
First Horizon Corporation
Primary
5Y
+59.2%
3Y
+53.8%
1Y
+40.1%
6M
+17.6%
1M
+6.5%
1W
-0.3%
EQH
Equitable Holdings, Inc.
Peer
5Y
+36.3%
3Y
+75.9%
1Y
-15.9%
6M
-14.8%
1M
+7.6%
1W
-1.5%
AEG
Aegon Ltd.
Peer
5Y
+139.0%
3Y
+64.7%
1Y
+22.4%
6M
+6.0%
1M
+0.4%
1W
+0.8%
AIZ
Assurant, Inc.
Peer
5Y
+91.8%
3Y
+90.7%
1Y
+14.3%
6M
+26.2%
1M
-3.5%
1W
-0.3%
ACG
Arch Capital Group Ltd.
Peer
5Y
+2.5%
3Y
+11.6%
1Y
+0.7%
6M
-5.5%
1M
-3.4%
1W
-1.5%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
12.17
Forward P/E
10.29
PEG Ratio
1.76
P/B Ratio
1.37
P/S Ratio
N/A
EV/Revenue
3.93
EV/EBITDA
N/A
Market Cap
$11.56B

Profitability

Profit margins and return metrics

Profit Margin 29.95%
Operating Margin 41.37%
Gross Margin N/A
ROE 11.26%
ROA 1.26%

Growth

Revenue and earnings growth rates

Revenue Growth +9.6%
Earnings Growth +29.3%
Q/Q Revenue Growth +22.76%
Q/Q Earnings Growth +20.6%

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
N/A
Current Ratio
N/A
Quick Ratio
N/A
Cash/Share
$9.6

Quarterly Earnings History

EPS performance vs analyst estimates

2026-07-15
$N/A
2026-04-15
$0.53
+6.7% surprise
2026-01-15
$0.52
+12.1% surprise
2025-10-15
$0.51
+14.6% surprise

Financial Services Sector Comparison

Comparing FHN against 763 companies in the Financial Services sector (133 bullish, 317 neutral, 313 bearish)
P/E Ratio
12.17
This Stock
vs
38.21
Sector Avg
-68.2% (Discount)
Return on Equity (ROE)
11.26%
This Stock
vs
-1.82%
Sector Avg
-718.4% (Below Avg)
Profit Margin
29.95%
This Stock
vs
75.74%
Sector Avg
-60.5% (Weaker)
Revenue Growth
9.6%
This Stock
vs
37.18%
Sector Avg
-74.2% (Slower)

Similar Companies

Peer comparison within the same industry

Recent Insider Trading

Insider buy and sell transactions from the last 6 months

DMUCHOWSKI HOPE
Chief Financial Officer
Stock Award
2026-02-11
27,043 shares
HUNG THOMAS
Officer
Stock Award
2026-02-11
12,740 shares
HART TANYA L
Officer
Stock Award
2026-02-11
10,616 shares
ARGO ASHLEY W
Officer
Stock Award
2026-02-11
8,012 shares
WISEMAN THOMAS LANG
General Counsel
Stock Award
2026-02-11
11,017 shares
FLEMING JEFF L.
Officer
Stock Award
2026-02-11
4,752 shares
LOCASCIO TAMMY S.
Chief Operating Officer
Stock Award
2026-02-11
27,944 shares
JORDAN DAVID BRYAN
Chief Executive Officer
Stock Award
2026-02-11
102,009 shares
RESTEL ANTHONY J
Officer
Stock Award
2026-02-11
27,944 shares
ARDOIN ELIZABETH A
Officer
Stock Award
2026-02-11
4,647 shares
JORDAN DAVID BRYAN
Chief Executive Officer
Sell
2026-01-29
85,009 shares · $2,054,164
JORDAN DAVID BRYAN
Chief Executive Officer
Option Exercise
2026-01-29
116,655 shares · $1,799,987
RESTEL ANTHONY J
Officer
Sell
2026-01-29
5,719 shares · $139,237
RESTEL ANTHONY J
Officer
Option Exercise
2026-01-29
8,182 shares · $130,994
JORDAN DAVID BRYAN
Chief Executive Officer
Gift
2025-12-22
42,000 shares
Insider transactions can signal confidence or concerns about company prospects

SEC Filings

Recent regulatory filings from the SEC EDGAR database

8-K
8-K
2026-04-15

Fairfax Financial Holdings Limited filed an 8-K to report its financial results for the first quarter of 2026.

DEF 14A
DEF 14A
2026-03-16

FHN filed a definitive proxy statement on March 16, 2026, providing shareholders with necessary information and voting materials for the upcoming annual meeting.

8-K
8-K
2026-03-12
10-K
10-K
2026-02-26

First Horizon Corporation (FHN) filed its 10-K annual report on February 26, 2026, providing comprehensive disclosures on its business operations and financial condition. While specific financial metrics were not included in the provided excerpts, the filing contains detailed sections on risk factors and management's discussion and analysis of results.

8-K
8-K
2026-01-15
10-Q
10-Q
2025-11-06

First Horizon Corporation (FHN) filed its 10-Q on November 6, 2025. The provided excerpts identify the inclusion of Risk Factors under Item 1A, although specific financial highlights and detailed risk disclosures were not available in the provided text.

8-K
8-K
2025-10-28

First Horizon Corporation (FHN) likely reported its third-quarter financial results in this 8-K filing dated October 28, 2025.

8-K
8-K
2025-10-15

First Horizon Corporation filed an 8-K on October 15, 2025, likely to announce its third-quarter financial results.

8-K
8-K
2025-08-21
8-K
8-K
2025-08-07
10-Q
10-Q
2025-08-07

First Horizon Corporation (FHN) submitted its 10-Q filing on August 7, 2025. While the filing includes a section dedicated to risk factors, specific financial highlights and detailed risk disclosures were not provided in the available excerpts.

8-K
8-K
2025-07-16
10-Q
10-Q
2025-05-07
8-K
8-K
2025-04-30
8-K
8-K
2025-04-29
Data sourced from SEC EDGAR. AI summaries generated automatically.

Wall Street Analysts

Professional analyst ratings and price targets

Consensus
BUY
19 analysts
DA Davidson
2026-04-16
Maintains
Neutral Neutral
Keefe, Bruyette & Woods
2026-04-16
Maintains
Market Perform Market Perform
Barclays
2026-04-07
Maintains
Overweight Overweight
UBS
2026-04-07
down
Buy Neutral
Evercore ISI Group
2026-04-06
Maintains
In-Line In-Line
JP Morgan
2026-04-01
Maintains
Neutral Neutral
Wells Fargo
2026-03-30
Maintains
Equal-Weight Equal-Weight
Citigroup
2026-02-24
Maintains
Buy Buy
Barclays
2026-01-16
Maintains
Overweight Overweight
DA Davidson
2026-01-16
Maintains
Neutral Neutral

Past News Coverage

Recent headlines mentioning FHN from our newsroom.

Newest → oldest
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI Chat
Markets
Profile